R&D Blueprint
The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crises.
Key actions by disease
Upcoming consultations
Useful resources
Accelerating R&D and Saving Lives
/photostory/2021-waaw-viet-nam/waaw-2021-viet-nam-photo-story-7.jpg?sfvrsn=12ba95bc_7 "A technician prepares a microscopic slide in a laboratory in Hanoi, Viet Nam")
Related activities
Online learning
All →/clinical-trials-for-new-re-emerging-pathogens-gpp-module-1.tmb-549v.png?sfvrsn=6d4247d9_1)
Documents
All →
12 March 2024
CORE Protocol - A phase 1/2/3 study to evaluate the safety, tolerability, immunogenicity, and efficacy...
This adaptive multi-stage, multi-arm Solidarity Against (Filoviruses) Vaccine study protocol is designed as a living protocol that will be used to study...
8 March 2024
Solidarity Partners – Platform adaptive randomized trial for new and repurposed Filovirus treatments...
This protocol was written in accordance with the trial design and drug selection recommendations from the Filovirus therapeutics working group at WHO....
10 October 2023
Landscape of Plague vaccine candidates
These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only.
10 October 2023
Global Research and Innovation for Health Emergencies
The COVID-19 pandemic has been at the centre of WHO’s research endeavours over the past 12 months and our progress is reported in alignment with...
Publications
All →
This large, international, randomized controlled clinical trial is designed to enable an expeditious, agile and concurrent evaluation of the benefits and...
10 April 2020
WHO R&D Blueprint COVID-19: Informal consultation on the potential inclusion of Favipiravir in a clinical...
There has been some suggestions for the inclusion of Favipiravir in the Solidarity trial.
Currently, there are no licensed vaccines for the prevention of COVID 19. While efforts continue to develop effective vaccines, it is pertinent to examine...
